ATE250082T1 - Derivate des antibiotikums a82846b (chloroorienticin a) - Google Patents

Derivate des antibiotikums a82846b (chloroorienticin a)

Info

Publication number
ATE250082T1
ATE250082T1 AT98303495T AT98303495T ATE250082T1 AT E250082 T1 ATE250082 T1 AT E250082T1 AT 98303495 T AT98303495 T AT 98303495T AT 98303495 T AT98303495 T AT 98303495T AT E250082 T1 ATE250082 T1 AT E250082T1
Authority
AT
Austria
Prior art keywords
derivatives
chloroorienticin
antibiotic
hexapeptides
disacc
Prior art date
Application number
AT98303495T
Other languages
English (en)
Inventor
Richard Craig Thompson
Stephen Charles Wilkie
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE250082T1 publication Critical patent/ATE250082T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT98303495T 1997-05-20 1998-05-05 Derivate des antibiotikums a82846b (chloroorienticin a) ATE250082T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4716597P 1997-05-20 1997-05-20

Publications (1)

Publication Number Publication Date
ATE250082T1 true ATE250082T1 (de) 2003-10-15

Family

ID=21947405

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98303495T ATE250082T1 (de) 1997-05-20 1998-05-05 Derivate des antibiotikums a82846b (chloroorienticin a)

Country Status (11)

Country Link
US (1) US5952310A (de)
EP (1) EP0879825B1 (de)
JP (1) JP4150430B2 (de)
AT (1) ATE250082T1 (de)
AU (1) AU7284798A (de)
CA (1) CA2290724C (de)
DE (1) DE69818144T2 (de)
DK (1) DK0879825T3 (de)
ES (1) ES2206840T3 (de)
PT (1) PT879825E (de)
WO (1) WO1998052596A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE361931T1 (de) * 1998-05-01 2007-06-15 Lilly Co Eli N1 modifizierte glycopeptide
CZ301184B6 (cs) 1998-12-23 2009-12-02 Theravance, Inc. Glykopeptidový derivát a farmaceutické prostredky, které jej obsahují
CA2623239C (en) 2005-09-22 2016-07-12 Medivas, Llc Solid polymer delivery compositions and methods for use thereof
JP5192384B2 (ja) 2005-09-22 2013-05-08 メディバス エルエルシー ビス−（α−アミノ）−ジオール−ジエステル含有ポリ（エステルアミド）およびポリ（エステルウレタン）組成物および使用の方法
CN102083862A (zh) 2008-04-01 2011-06-01 康奈尔大学 有机-可溶性壳聚糖盐和由其制备的壳聚糖衍生生物材料
CN102250221A (zh) * 2010-05-19 2011-11-23 复旦大学 万古霉素类衍生物及其制备方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698327A (en) * 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
US4643987A (en) * 1985-08-14 1987-02-17 Eli Lilly And Company Modified glycopeptides
EG18377A (en) * 1986-09-19 1993-04-30 Lilly Co Eli Process for preparing glycopeptide antibiotics
US5534420A (en) * 1988-07-28 1996-07-09 Eli Lilly And Company Biotransformation of glycopeptide antibiotics
DK0409045T3 (da) * 1989-07-18 1997-12-22 Biosearch Italia Spa Pentapeptidantibiotika afledt fra dalbaheptider.
CA2031803C (en) * 1989-12-13 2001-05-29 Ramakrishnan Nagarajan Improvements in or relating to glycopeptide deriveratives
TW213468B (de) * 1991-06-29 1993-09-21 Hoechst Ag
AU703106B2 (en) * 1994-01-28 1999-03-18 Eli Lilly And Company Glycopeptide antibiotic derivatives
US5919756A (en) * 1996-06-28 1999-07-06 Eli Lilly And Company Amides

Also Published As

Publication number Publication date
DE69818144D1 (de) 2003-10-23
US5952310A (en) 1999-09-14
EP0879825A2 (de) 1998-11-25
CA2290724C (en) 2010-03-23
CA2290724A1 (en) 1998-11-26
DE69818144T2 (de) 2004-07-15
EP0879825A3 (de) 1999-11-24
PT879825E (pt) 2004-02-27
JP2001526681A (ja) 2001-12-18
DK0879825T3 (da) 2004-02-02
JP4150430B2 (ja) 2008-09-17
EP0879825B1 (de) 2003-09-17
WO1998052596A1 (en) 1998-11-26
ES2206840T3 (es) 2004-05-16
AU7284798A (en) 1998-12-11

Similar Documents

Publication Publication Date Title
WO1998007745A3 (en) Compositions and methods for treating infections using analogues of indolicidin
DE69711766D1 (de) Derivate von Amiden glycopeptidischer Antibiotica
EA200300050A1 (ru) Гликопептидфосфонатные производные
PT688789E (pt) Processo de lipopeptideos processo para a sua preparacao e sua utilizacao
EP0881229A3 (de) Antibiotisch wirksame, alkylierte Hexapeptide
ATE331037T1 (de) Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff
ATE250082T1 (de) Derivate des antibiotikums a82846b (chloroorienticin a)
ATE361931T1 (de) N1 modifizierte glycopeptide
AU5696298A (en) Keratinocyte growth factors and uses thereof
ITRM940221A0 (it) Procedimento per il trattamento superficiale di cilindri di apertura per la filatura ad estremita' aperta.
EP1174439A3 (de) Zusammensetzungen und Methoden zur Behandlung von Infektionen unter Verwendung von Indolicidinanalogen
WO2001098326A3 (en) Glycopeptide disulfide and thioester derivatives
EP0881230A3 (de) Harnstoff- und Thioharnstoffderivate von antibiotisch wirksamen Glykopeptiden
NO20023761L (no) Selektiv N-acylering av A82846 glykopeptidanaloger
EP0722714A3 (de) Benzoxazolderivate, ihre Verwendung als Sonnenschutzmittel und die Benzoxazolderivate enthaltende kosmetische Zusammensetzungen
ATE204286T1 (de) Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge
TWI231815B (en) Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents
EP1122245A3 (de) 2-Amino-Benzoxazinone zur Behandlung von viralen Infektionen
MXPA03009803A (es) Antibioticos de glicopeptidos.
EP1390056A4 (de) Glycopeptid-antibiotika
AU4063793A (en) Aqueous hexapeptide compositions
AUPQ053299A0 (en) The "cylseal" postal cylinder seal

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0879825

Country of ref document: EP

REN Ceased due to non-payment of the annual fee